<DOC>
<DOCNO>
EP-0008402
</DOCNO>
<TEXT>
<DATE>
19800305
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-207/333</main> C07C-119/20 C07D-207/00 C07D-207/32 C07D-207/333 
</IPC-CLASSIFICATIONS>
<TITLE>
2-(o-hydroxyphenyl)-pyrrole and process for its preparation.
</TITLE>
<APPLICANT>
basf agde<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende <sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
engel norbert  <sep>franke albrecht dr chem<sep>frickel fritz-frieder dr chem<sep>koenig horst dr chem<sep>steglich wolfgang dr chem<sep>engel, norbert<sep>franke, albrecht, dr. chem.<sep>frickel, fritz-frieder, dr. chem.<sep>koenig, horst, dr. chem.<sep>steglich, wolfgang, dr. chem.<sep>engel, herbert, dr.goethestrasse 12d-5300 bonnde<sep>franke, albrecht, dr. chem.mandelring 11d-6706 wachenheimde<sep>frickel, fritz-frieder, dr. chem.prager strasse 27d-6700 ludwigshafende<sep>koenig, horst, dr. chem.pariser strasse 4d-6700 ludwigshafende<sep>steglich, wolfgang, dr. chem.am klostergarten 3d-5300 bonnde<sep>engel, herbert, dr.<sep>franke, albrecht, dr. chem.<sep>frickel, fritz-frieder, dr. chem.<sep>koenig, horst, dr. chem. <sep>steglich, wolfgang, dr. chem.<sep>engel, herbert, dr. goethestrasse 12 d-5300 bonn de <sep>franke, albrecht, dr. chem.mandelring 11d-6706 wachenheimde<sep>frickel, fritz-frieder, dr. chem.prager strasse 27d-6700 ludwigshafende<sep>koenig, horst, dr. chem.pariser strasse 4d-6700 ludwigshafende<sep>steglich, wolfgang, dr. chem.am klostergarten 3d-5300 bonnde<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to the compound 2- (O-hydroxyphenyl) pyrrole and a method for its manufacture, in which O-benzyloxybenzoic acidallylamide is reacted in an inert solvent with phosgene which cyclizes obtained imide chloride in the presence of a strong sterically hindered base and then theBenzyl protection group hydrogenolytically splits.The 2- (O-hydroxyphenyl) pyrrole is a valuable intermediate product for the synthesis of drugs, in particular, alkylamino-hydroxypropyl ether can be used because of their Î²-sympatholytic effects for the treatment of coronary heart disease, cardiac arrhythmias and hypertension.
</ABSTRACT>
</TEXT>
</DOC>
